IL2 and brain neoplasm: The ommaya reservoir or infusion pumps have thus far been used in various clinical trials with brain tumor patients to interstitially deliver the chemotherapeutic agents BCNU or its analogs, methotrexate, adriamycin, bleomycin, fluodeoxyuridine, cisplatin, and interleukin 2(IL-2).